Sector: Life Sciences

Latest content

Four developments to watch out for in the mRNA patent wars this year

Disputes over vaccine technology will continue to occupy headlines in 2023

03 January 2023

Brazilian patent term decision quashed and other 2022 Latin America developments

IAM looks back at some key stories from Brazil and Colombia over the last 12 months

29 December 2022

The five stories that made 2022 a pivotal year for life sciences IP

IAM looks back at the most important pharmaceuticals developments of the past 12 months

28 December 2022

US omnibus appropriations bill: robust USPTO funding and satellite office incoming

Unleashing American Innovators in, Pride in Patent Ownership out of bill which is expected to hit Biden’s desk on Friday

20 December 2022

An almost billion-dollar award leads 2022’s top 10 US patent verdicts

Companies who scored the most from US juries during the past 12 months include VLSI Technology, Complete Genomics Inc, Ravgen Inc, USAA and Columbia University

19 December 2022

Intellectual Property Owners Association backs US study on covid therapeutics prior to TRIPS waiver extension

Yielding patent protection rights won’t make products magically appear, says IPO Treasurer Dan Enebo

16 December 2022

Patent bills prominent but prospects mixed as US Congress winds down

Controversial Pride in Patent Ownership bill unlikely, other bills passed or possible

16 December 2022

Amgen’s $28 billion Horizon buyout is the latest deal driven by patent cliff fears

The year’s largest acquisition sees several IP-backed rare disease treatments change hands

15 December 2022

The dangers of basing preliminary injunctions on determination of evidence

Pharmaceutical patent holders have the unenviable task of providing evidence before IP courts to prove infringement to obtain a preliminary injunction decision to prevent launch of the infringing product to the market. Unfortunately, disparities in Turkish courts’ approaches to requests for determination of evidence are making a challenging job even harder.

14 December 2022

Diversity data reveals size of missed opportunities in inventors and patenting

Qualcomm executive and Invent Together director discuss initiatives at IP Dealmakers conference in New York

13 December 2022

• <
• 1
• ...
• 2
• 3
• 4
• 5
• ...
• 6
• 7
• 8
• 9
• 10
• ...
• >